Gene · 1109
Papers1,988
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,988
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metastatic triple negative breast cancer adapts its metabolism to destination tissues while retaining key metabolic signatures. | Proc Natl Acad Sci U S A | 2022 | 35994654 | PubTator, text mining | PubMed |
| How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation? | Front Oncol | 2022 | 35965558 | PubTator, text mining | PubMed |
| Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma. | BMC Cancer | 2022 | 35953777 | PubTator, text mining | PubMed |
| Reductive Al-B σ-Bond Formation in Alumaboranes: Facile Scission of Polar Multiple Bonds. | Angew Chem Int Ed Engl | 2022 | 35947518 | PubTator, text mining | PubMed |
| Glycan shield of the ebolavirus envelope glycoprotein GP. | Commun Biol | 2022 | 35927436 | PubTator, text mining | PubMed |
| An imaging mass cytometry immunophenotyping panel for non-human primate tissues. | Front Immunol | 2022 | 35911721 | PubTator, text mining | PubMed |
| The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression. | Front Oncol | 2022 | 35903688 | PubTator, text mining | PubMed |
| Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection. | Sci Rep | 2022 | 35896770 | PubTator, text mining | PubMed |
| Predicting Elastic Constants of Refractory Complex Concentrated Alloys Using Machine Learning Approach. | Materials (Basel) | 2022 | 35888464 | PubTator, text mining | PubMed |
| SOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner. | Biomedicines | 2022 | 35884771 | PubTator, text mining | PubMed |
| Pyrene-Based AIE Active Materials for Bioimaging and Theranostics Applications. | Biosensors (Basel) | 2022 | 35884351 | PubTator, text mining | PubMed |
| Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients. | Cells | 2022 | 35883650 | PubTator, text mining | PubMed |
| Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types. | BMC Bioinformatics | 2022 | 35879674 | PubTator, text mining | PubMed |
| Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer. | Br J Cancer | 2022 | 35869144 | PubTator, text mining | PubMed |
| Case Report: Severe Gonadal Dysgenesis Causing 46,XY Disorder of Sex Development Due to a Novel NR5A1 Variant. | Front Genet | 2022 | 35865014 | PubTator, text mining | PubMed |
| Ambiguous structure determination from powder data: four different structural models of 4,11-di-fluoro-quinacridone with similar X-ray powder patterns, fit to the PDF, SSNMR and DFT-D. | IUCrJ | 2022 | 35844476 | PubTator, text mining | PubMed |
| Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1. | Cell Mol Gastroenterol Hepatol | 2022 | 35843546 | PubTator, text mining | PubMed |
| High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm. | Front Immunol | 2022 | 35833148 | PubTator, text mining | PubMed |
| Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). | Cell Death Dis | 2022 | 35831283 | PubTator, text mining | PubMed |
| Single-cell atlas of craniogenesis uncovers SOXC-dependent, highly proliferative, and myofibroblast-like osteodermal progenitors. | Cell Rep | 2022 | 35830813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1109/papers?page=15